Business Services Industry
ALCON DEVELOPS NEW FORMULATION OF PATANOL OPHTHALMIC SOLUTION.
AsiaPulse News, January, 2003
$all $us $anr $dru
(Full text of a statement. Contact details below.)
FORT WORTH, Texas, Jan. 23 /PRNewswire-FirstCall-Asianet/ -- Alcon, Inc. (NYSE: ACL) will present the results from two clinical trials involving a new, investigational once-daily formulation of the company's flagship brand PATANOL(R) at the annual meeting of the Western Society of Allergy, Asthma & Immunology (WSAAI) in Hawaii this week.
The first study investigated the product's safety and efficacy up to 24 hours after dosing, while the second evaluated the safety of the drug. This new formulation of PATANOL solution is intended for the once-daily treatment of ocular allergy.
In the first clinical trial, adult subjects were given the study medication once and then...
Most Recent Business Articles
- Multiple criteria evaluation and optimization of transportation systems
- Multi-criteria analysis procedure for sustainable mobility evaluation in urban areas
- A two-leveled multi-objective symbiotic evolutionary algorithm for the hub and spoke location problem
- Multi-criteria analysis for evaluating the impacts of intelligent speed adaptation
- The development of Taiwan arterial traffic-adaptive signal control system and its field test: a Taiwan experience
Most Recent Business Publications
Most Popular Business Articles
- 7 tips for effective listening: productive listening does not occur naturally. It requires hard work and practice - Back To Basics - effective listening is a crucial skill for internal auditors
- FAS 109: a primer for non-accountants - Financial Accounting Standards Board's "Statement 109: Accounting for Income Taxes"
- Design a commission plan that drives sales - Sales Commissions
- Too Young to Rent a Car? - 25-years-old the minimum age for car renting - Brief Article
- LIFO vs. FIFO: a return to the basics
